YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(47)
- China(12)
- Colombia(1)
- Denmark(1)
- Finland(2)
- France(9)
- Germany(34)
- Greece(1)
- Hong Kong(1)
- Hungary(1)
- India(67)
- Ireland(1)
- Israel(2)
- Italia (6)
- Japan(1)
- Luxembourg(1)
- Malta(1)
- Mauritius(1)
- Mexico(1)
- Peru(1)
- Poland(1)
- Portugal(3)
- Singapore(1)
- Slovenia(1)
- South Korea(3)
- Spain(9)
- Sweden(2)
- Switzerland(19)
- Taiwan(2)
- The Czech Republic(1)
- The Netherlands(3)
- Turkey(1)
- Ukraine(1)
- United Kingdom(46)
- United States(583)
- Vietnam(1)
Contract Service Directory
Rentschler Biopharma
Company Headquarters
Erwin-Rentschler-Str. 21
Laupheim, 88471
Germany
Company Description
Rentschler Biopharma, a leading contract development and manufacturing organization (CDMO), focuses exclusively on client projects. From its headquarters in Laupheim, Germany, and its site in Milford, MA, USA, the company offers cGMP process development and manufacturing of biopharmaceuticals as well as project management and regulatory support.
Contract Service Directory
- Accelerated Stability Studies
- Analytical Methods Development
- Analytical Validation Studies
- Bioanalytical Analysis LC/MS/MS
- Bioanalytical Services
- Biologics Manufacturing
- Biologics Process Development
- Bioprocess Validation
- Bioprocessing
- Bioprocessing, Disposable/Single-Use
- Cell Line Construction & Development
- CMC (Chemistry, Manfacturing & Controls)
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Custom Manufacturing
- Downstream Processing
- Formulation Development
- Mammalian Cell Culture
- Manufacturing, Biologics
- Manufacturing, Proteins
- Methods Validation
- Process Characterization
- Process Development/Scale-Up Services
- Process Validation Studies
- Project Management
- Purification
- QA/QC
- Regulatory Affairs Consultants
- Scale-Up
- Stability Studies
- Technology Transfer
Contract Services Directory
Related Content
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Rentschler Expands Complex Antibodies Production in Germany
Expands capacity with 2,000-liter bioreactor to address increasing demand for complex antibodies.06.30.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances
Vetter, Rentschler Biopharma Advance Strategic Alliance
Sets up a governance structure and implements guidelines for joint manufacturing services to support clients.Kristin Brooks 04.28.21
-
Breaking News | Industry News | Promotions & Moves
Rentschler Biopharma Names Martin Kessler as New CEO in U.S.
Will drive company-wide transformation and lead the ongoing expansion at the U.S. site.Tim Wright, Editor, Contract Pharma 03.31.21
-
Breaking News | Formulation Development | Industry News
Rentschler, Leukocare Extend Service Offering with U.S. Site
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.Kristin Brooks 03.22.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CureVac, Rentschler Ramp up COVID Vax Production
Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.Kristin Brooks 02.01.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Rentschler Biopharma and Vetter Enter Partnership
Two CDMOs team up with joint goal to simplify processes and optimize time-to-market.Contract Pharma Staff 07.06.20
-
Bio News | Breaking News | Industry News | Promotions & Moves
Rentschler Biopharma Appoints New Executives to Join U.S. Team
New heads of Process Sciences and Human Resources departments.11.20.19
-
CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
The arrival of patient-centric CDMO’s predicted by CPhI Annual Report.11.14.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Rentschler Kicks Off Expansion at U.S. Facility
New 500 L bioreactor in operation mid-2020 at U.S. site.11.11.19
-
Bio News | Breaking News | Industry News
Nikolaus Rentschler and Frank Mathias are "EY Entrepreneur of the Year"
Rentschler Biopharma management duo received the award on October 25.11.01.19
-
cGMP Manufacture | Drug Development
Contract Pharma’s 20th Anniversary Series: CDMO Insight
JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.Kristin Brooks, Contract Pharma 11.01.19
-
Regulatory Affairs | Serialization
Fighting Back!
The drug industry takes a bare-knuckle approach to drug counterfeiters.Daniela Geiger, Vetter 10.04.19
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Rentschler Expands Collaboration with Summit
New contracts secured with Japanese pharmaceutical companies10.04.19
-
Breaking News | Industry News | Regulatory Affairs
LSNE's Spain Site Gets FDA Approval
LSNE-León is the fourth facility to gain commercial approval10.04.19
-
Cytotoxics and High Potency Manufacturing
-
Breaking News | Industry News | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
Upperton Pharma Solutions Investment Increases Tabletting Capabilities
New Futorque X tablet press is designed to support R&D studies and production batches09.16.19
-
cGMP Manufacture | Clinical Trial Materials | Industry News
Rentschler Biopharma Takes on New Projects at Milford, MA Facility
The site will support both clinical and commercial manufacturing programs09.04.19
-
Breaking News | Industry News | Inspections
Bora Secures FDA Approval for CDMO Services
Reports successful inspection of Zhunan, Taiwan site09.03.19
-
Preparing for Your CDMO Selection Process
Finding the CDMO that is right for your company and project can be a daunting task, particularly if this is your first time outsourcing.
-
APIs | Breaking News | Industry News
-
Breaking News | Fill/Finish | Industry News | Promotions & Moves
Rentschler Fill Solutions Names Friedrich Sernetz as CEO
Collaboration in operations strengthens strategic alliance between Rentschler Fill Solutions GmbH and Rentschler Biopharma SE06.10.19
-
Breaking News | Promotions & Moves
Rentschler Biopharma Appoints Project Management SVP
Dr. Hunzinger brings 15 years of industry experience in biopharmaceutical R&D01.29.19
-
Breaking News | cGMP Manufacture | Industry News
Rentschler Biopharma Completes Acquisition of U.S. Mfg. Site
Rentschler will continue to manufacture for Shire at the 93,000 sq.-ft. site in Milford, MA01.03.19
-
Bio News | Industry News | Promotions & Moves
Rentschler Biopharma Appoints Mfg. VP
With over 15 years experience, Henning Gerschewski will serve as vice president Manufacturing Science and Technology, effective January 01, 2019.12.20.18
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Rentschler Biopharma Buys U.S. Mfg. Site from Shire
Will leverage the development and manufacturing site for CDMO services12.17.18
-
Bio News | Industry News | Promotions & Moves
Rentschler Biopharma Appoints Innovation SVP
Dr. Jesús Zurdo will provide scientific leadership for development and manufacturing services from cell-line development through to final product manufacturing12.13.18
-
Aseptic Processing | Breaking News | cGMP Manufacture | Facilities | Fill/Finish | Industry News
Rentschler Inaugurates New Fill and Finish Facility
New high-tech facility to be used for the aseptic filling and freeze-drying of drug products11.20.18
-
Bio News | Industry News | Promotions & Moves
Rentschler Fill Solutions Makes Key Hire
With over two decades experience, Dr. Margit Klotz joins the company as general manager, Operations07.23.18
-
Fill/Finish | Industry News
Rentschler Fill Solutions, Ultragenyx in Fill/Finish Pact
Rentschler to provide fill/finish services for the U.S. commercial supply of Mepsevii05.30.18
-
Bioanalytical Services | Industry News | Information Technology | Promotions & Moves
Rentschler Biopharma Appoints New VP
Dr. Thomas Rösch boasts over 16 years of industry experience, and will head the Biopharma Engineering & Technology unit03.28.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Rentschler Biopharma, Leukocare Report Successful Alliance
First year of alliance delivers project wins, including four with U.S.-based clients03.09.18
-
Bio News | Drug Development | Industry News | Promotions & Moves
Rentschler Biopharma Appoints SVP
Federico Pollano comes with over two decades of experience, and will head the business development unit02.28.18
-
Biologics, Proteins, Vaccines | Drug Development | Industry News | Promotions & Moves
